DNV Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Investments
  • 37

  • Portfolio
  • 17

  • Exits
  • 19

Exits

DNV Capital General Information

Company Description

DiNova Venture Capital global venture capital firm. The company focuses on medical industries. It specializes in medical treatment particularly medical equipment and services. It seeks to make early to growth stage investments in high-end medical technology and E-health. As of May 2015, Dinova Capital has invested 13 deals in Europe and America, 3 deals in China. The company is headquartered in Shenzhen, China.

Business Details

Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Corporate Office
  • Suite 230 Changhong Tech Building, Keji South Road
  • Nanshan District
  • Shenzhen, Guangdong 518000
  • China
+86 0755

DNV Capital Investments (37)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sinovation 28-Jun-2023 Later Stage VC Surgical Devices Generating Revenue
T-Ray Technology 01-May-2023 Connectivity Products Generating Revenue
SHURUI 23-Mar-2023 Surgical Devices Generating Revenue
PINS Medical 03-Jan-2023 Therapeutic Devices Generating Revenue
Direct Flow Medical 10-Aug-2022 Surgical Devices Profitable
Binhui Biopharm 28-Mar-2022 Biotechnology Generating Revenue
Shanghai Outai 01-Jan-2022 Surgical Devices Generating Revenue
Xuanzhu Biopharm 31-Dec-2021 Drug Discovery Clinical Trials - General
Metronom Health 23-Dec-2020 Later Stage VC Monitoring Equipment Generating Revenue
Cyrano Therapeutics 04-Nov-2020 Later Stage VC Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 37 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNV Capital Exits (19)

Company Name Exit Date Exit Type Exit Size
Xuanzhu Biopharm 15-Nov-2024 Secondary Transaction - Private
Hinova Pharmaceuticals 12-Apr-2022
CANbridge Pharma 10-Dec-2021
Sonendo 29-Oct-2021
Broncus Medical 13-Sep-2021
Human Xtensions 01-Dec-2020
Venus Medtech 10-Dec-2019
Sorrento Therapeutics 28-Jun-2019
Mitralign 12-Mar-2019 Merger/Acquisition
LoneStar Heart 01-Jul-2018 Out of Business
You’re viewing 10 of 19 exits. Get the full list »

DNV Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

DNV Capital FAQs

  • What is DNV Capital?

    DiNova Venture Capital global venture capital firm.

  • When was DNV Capital founded?

    DNV Capital was founded in 2011.

  • Where is DNV Capital headquartered?

    DNV Capital is headquartered in Shenzhen, China.

  • What is DNV Capital's total asset value?

    DNV Capital has around in total assets under management.

  • How many investments has DNV Capital made?

    DNV Capital has made 37 investments.

  • What has DNV Capital invested in?

    DNV Capital has made numerous investments in companies like Sinovation, T-Ray Technology, and SHURUI within the Surgical Devices and Connectivity Products industries.

  • What has DNV Capital invested in recently?

    DNV Capital's latest investment was on 28-Jun-2023 in Sinovation, a company within the Surgical Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »